Daniel Newman Mendelson, Director at CHAMPIONS ONCOLOGY, INC. (CSBR), bought 1,500 shares at $5.95 ($9K) on 2023-09-27, disclosed to the SEC on 2023-10-16.
Open-market purchase of $9k CSBR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| Filing → |
| CSBR | BUY | 2024-01-11 | $19K | — | Filing → |
| CSBR | BUY | 2024-01-10 | $19K | — | Filing → |
| CSBR | BUY | 2024-01-09 | $6K | — | Filing → |